Welcome to our dedicated page for GE Aerospace news (Ticker: GE), a resource for investors and traders seeking the latest updates and insights on GE Aerospace stock.
GE Aerospace (NYSE: GE) is a global aerospace propulsion, services, and systems company with an installed base of tens of thousands of commercial and military aircraft engines. The GE news feed on Stock Titan highlights official announcements, customer agreements, technology collaborations, and capital markets disclosures that shape the company’s role in aviation.
News items often feature engine selection and purchase agreements with airlines and aviation groups for families such as GEnx and GE9X, including orders that cover engines, spare units, and long-term services support. These stories provide insight into how airlines are planning fleet growth, widebody expansion, and long-haul route development using GE Aerospace propulsion.
Investors and aviation followers will also find coverage of service and leasing partnerships, such as lease pool management arrangements for GE9X, GEnx, GE90, CF6, and CF34 engines. These updates explain how GE Aerospace and its partners manage shop visits, lease returns, and technical support to keep fleets operating reliably.
The news stream includes technology and innovation updates, including collaborations to develop hybrid electric turbogenerators for Advanced Air Mobility and work on integrated hybrid electric propulsion systems. Announcements about defense propulsion, such as the use of F110 engines and propulsion support for autonomous VTOL aircraft, highlight the company’s presence in military and next‑generation applications.
Additional releases cover corporate actions such as regular quarterly dividend declarations, leadership changes disclosed via SEC filings, and community and education initiatives, including scholarship programs supported by the GE Aerospace Foundation. For readers tracking GE Aerospace, this news page offers a centralized view of customer deals, technology milestones, governance developments, and strategic partnerships. Bookmark this page to monitor how GE Aerospace’s engine programs, services, and collaborations evolve over time.
GE Healthcare leads the US FDA's updated list of AI-enabled medical devices with 42 authorizations, reflecting the company's robust AI strategy aimed at enhancing healthcare efficiency, outcomes, and interoperability. The company utilizes its Edison Health Services platform to integrate data from diverse sources, supporting clinical applications. Innovations like Air Recon DL and Critical Care Suite 2.0 exemplify GE's commitment to improving patient care through AI-driven solutions. With $17.7 billion in revenue and a global workforce of around 48,000, GE Healthcare aims to revolutionize healthcare services through data-driven technology.
GE Healthcare and AMC Health have announced a partnership to enhance Remote Patient Monitoring (RPM) capabilities. This collaboration extends patient care from hospitals to home environments, utilizing GE's acute monitoring technology and AMC's FDA-cleared RPM solutions. With over 133 million Americans living with chronic diseases, this initiative aims to reduce hospital admissions by allowing real-time monitoring and analytics for better patient management. The RPM solutions will integrate with GE's existing healthcare platforms, aiming to deliver comprehensive care beyond hospital walls.
GE Healthcare has partnered with Tribun Health to enhance digital pathology solutions for oncology. This collaboration will integrate Tribun's Health Suite into GE's products, notably improving data management through the vendor neutral archive (VNA) and Edison Datalogue. The goal is to streamline the oncology care pathway, facilitating prompt and accurate pathology reporting via AI technology. As global oncology cases rise, this partnership addresses the pressing need for efficient data-driven healthcare solutions.
GE Digital has unveiled FlightPulse® for Business Jets at the NBAA-BACE, an advanced Electronic Flight Bag application aimed at enhancing operational safety for pilots. Developed in collaboration with Gulfstream Aerospace, this software provides critical flight data, enabling informed decision-making. Features include pre- and post-flight analytics tools designed for user-friendliness. FlightPulse integrates with GE's existing safety programs, boosting data access for more than 350 corporate flight departments. The product showcases GE Digital's commitment to improving aviation safety and efficiency.
Telix Pharmaceuticals has announced a strategic agreement with GE Healthcare to integrate their investigational PET imaging radiotracers, TLX250-CDx and [18F]-FLac, into GE's immuno-diagnostic portfolio. These tracers evaluate tumor metabolism, aiding in patient selection for immunotherapy. The collaboration aims to enhance clinical research offerings, with GE responsible for marketing while Telix manages product development. This five-year agreement could significantly influence oncology treatments by improving therapy selection and monitoring.
GE Healthcare unveiled its innovative Omni Legend at the EANM Annual Meeting. This all-digital PET/CT system features a novel digital BGO detector, enhancing sensitivity by over 2 times and reducing scan times by up to 53%. The system aids in oncology, cardiology, and neurology procedures, with impressive small lesion detectability increases of up to 20%. With Precision DL and other AI-driven features, it promises operational efficiency and improved patient throughput.
Current has appointed Smart Lighting Solutions as the new representative for its HLI Brands Portfolio in Georgia. This partnership aims to enhance the specification of Current's advanced lighting and connected controls, recognized for their reliability. Smart Lighting Solutions, an established agency since 2014, operates two locations in North and South Georgia and focuses on delivering quality service in lighting systems. Current also plans to announce new representation in Northern Florida soon, indicating further growth opportunities.
Summary not available.
GE Healthcare has established a long-term agreement with Sociedad Quimica y Minera de Chile S.A. (SQM) to secure a reliable supply of iodine, essential for contrast media in X-Ray and CT imaging. This partnership aims to address rising global demand, targeting an additional 30 million patient doses annually by 2025. As part of the investment plan, GE Healthcare will open a $30 million manufacturing line at its Cork, Ireland facility this week, enhancing production capabilities amidst a doubling expected in iodine contrast media demand over the next decade.
GE has officially filed the Form 10 registration statement for the spin-off of its healthcare division, GE HealthCare, marking a critical step in its transformation into three standalone companies. This move aims to enhance operational focus and capability in a rapidly growing $84 billion global medical technology market. GE anticipates the completion of this spin-off in the first week of 2023, retaining a 19.9% stake in GE HealthCare. The spin-off is expected to be tax-free for shareholders, allowing GE HealthCare to concentrate on precision health innovation and serve its customers more effectively.